CLINICAL_TRIALS
trial_result
· 2013-01-04
Clinical Trial Update: Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer [Phase 2]
Summary
Phase 2 clinical trial update for cetuximab in recurrent or advanced non-small cell lung cancer (stage IIIB/IV).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eastern Cooperative Oncology Group | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-01-04